drugset / Trial / NCT01855360
Doxycycline and TUDCA in Patients With Transthyretin Amyloid Cardiomyopathy
NaSingle-groupOpen-labelTreatment
Summary
The objective of the study is to determine whether the combination of the bile acid TUDCA, and doxycycline will slow the progression of familial and senile amyloidosis.
Timeline
- Start
- 2013-06
- Primary completion
- 2015-05-31
- Completion
- 2015-05-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Doxycycline | Small molecule | 100 mg | Oral |
| Subject | Doxycycline | Small molecule | 200 mg | Oral |
| Subject | Taurursodiol | Small molecule | 250 mg | Oral |